Practice
Featured experience
Nordson $800 million acquisition of Atrion
We are advising Nordson on the acquisition
Gilead Sciences $4.3 billion acquisition of CymaBay Therapeutics
We are advising Gilead Sciences on the acquisition
Owens Corning $3.9 billion acquisition of Masonite International
We are advising Owens Corning on the acquisition
Equinix $2 billion at-the-market offering
We advised Equinix on the offering
Natus Medical $1.2 billion acquisition by ArchiMed
We are advising Natus Medical on the transaction
Xponential Fitness $103.5 million secondary offering
The shares are listed on the New York Stock Exchange
Charles River Laboratories $295 million acquisition of Explora BioLabs Holdings
We advised Charles River on the transaction
Equinix $1.2 billion green bonds offering
We advised Equinix on the investment-grade debt offering
Grupo Aval spinoff of BAC Holding International
We advised Grupo Aval on the unregistered spinoff of a 75% equity stake in its indirect subsidiary
HP $3.3 billion acquisition of Poly
We are advising HP on the transaction
Banco Santander $2.75 billion senior preferred and non-preferred notes offering
We advised Banco Santander on its offering of fixed-rate and fixed-to-fixed-rate notes
JPMorgan Chase €2.5 billion notes offering
We advised JPMorgan Chase on the euro notes offering
Toyota Motor Credit $3 billion notes offering
We advised TMCC on the SEC-registered offering
NatWest Markets $1.5 billion notes offering
We advised NatWest Markets on its Rule 144A medium-term notes program update and notes offering